With Gains Of 2300% Or More, Which Of These Best-Performing Coronavirus Stocks Are Buys?

With year-to-date gains of 2300%, 3300% and 3400%, respectively, the three stocks that are the focus of today’s article – two biotechs and a molecular diagnostics company – are the best-performing coronavirus stocks so far this year. And while all three have the potential to continue their upwards trajectories throughout the rest of 2020 and into 2021, the author believes only one is a buy right now – at least for aggressive investors. For more, CLICK HERE.